Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,930.00
Bid: 11,850.00
Ask: 12,300.00
Change: 0.00 (0.00%)
Spread: 450.00 (3.797%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 11,930.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks manage gains on globally quiet day

Mon, 19th Feb 2024 15:59

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

The FTSE 100 index rose by 0.22%, reaching a value of 7,728.50 points, while the FTSE 250 index saw gains of 0.13%, closing at 19,216.90 points.

On a relatively quiet global day with Wall Street closed for the Presidents' Day holiday, Currys surged amid reported takeover interest.

In currency markets, sterling was last down 0.13% on the dollar, trading at $1.2586, while it saw a drop of 0.05% against the euro to change hands at €1.1686.

"Chinese markets ended the day in positive territory with the Shanghai Composite closing at six-week highs on the first trading day after the Lunar New Year break," said IG senior market analyst Axel Rudolph.

"Positive tourism revenues data during the holidays and an unchanged one-year medium-term lending facility rate propped up Chinese equities and led to gains in the region at large.

"The FTSE 100 has begun this week where it left off last week by outperforming its European peers during an extremely quiet session as US stock markets were closed for Presidents' Day."

Rudolph added that oil prices had risen amid the quiet trading, as European natural gas futures fell to an eight-month low.

"The gold price appreciated slightly despite the dollar regaining some of its recently lost ground in low volume and low volatility trading ahead of Wednesday's FOMC minutes."

Housing market shows resilience in February

In economic news, the housing market showed resilience in February, bolstered by a continuation of declining mortgage rates, according to fresh industry data.

Rightmove's latest house price index showed a notable uptick, with average new seller prices increasing 0.9% compared to the prior month, and by 0.1% year-on-year.

That marks the first time in six months that the annual price change had entered positive territory.

In January, house prices experienced a month-on-month increase of 1.3%, although they recorded a year-on-year decline of 0.7%.

The average asking price for homes now stood at £362,839.

Additionally, agreed sales during the initial six weeks of 2024 surged 16% compared to the same period a year earlier.

Furthermore, there were notable increases in both new listings and buyer enquiries, which rose by 7% each year-on-year.

"Early-bird Boxing Day buyers got a head start in cherry-picking from a record level of new property choice and have now been joined by many other buyers also believing that 2024 offers the right market conditions to move," said Tim Bannister, director of property science at Rightmove.

"Mortgage rates have fallen considerably from their peak and are now remaining broadly stable after the uncertainty of late 2022 and 2023.

"Momentum to move in 2024 is continuing to build."

Currys surges on takeover talk, Moneysupermarket in the red

On London's equity markets, Currys rocketed 36.36% after confirmations from US private equity firm Elliott Advisors and Chinese e-commerce giant JD.com, both considering separate bids for the struggling British electrical retailer.

Currys said it had rejected a £700m proposal from Elliott, citing undervaluation of the chain and its future prospects.

Elsewhere, Rolls-Royce Holdings gained 2.68% ahead of its full-year results scheduled for Thursday.

AstraZeneca rallied 2.62% following approval from the US Food and Drug Administration (FDA) for a combination of its cancer drug Tagrisso with chemotherapy to treat a type of lung cancer.

SSE and Bank of Georgia Group recorded more modest gains, with SSE benefiting from an upgrade to 'buy' at Jefferies, and Bank of Georgia rising after agreeing to acquire Armenian bank Ameriabank for $303.6m.

On the downside, Moneysupermarket Group declined 1.7%, despite reporting record full-year revenues driven by its insurance business's strong performance.

Anglo American also faced a downturn, dropping 1.37%, after it announced a restructuring in its platinum arm, potentially affecting over 4,300 jobs due to lower prices and higher costs amid a global economic slowdown.

Flutter Entertainment closed in the red, losing 1.29%, despite Berenberg raising its price target on the shares and reiterating its 'buy' recommendation.

Berenberg emphasised Flutter's strong growth and balance sheet flexibility, highlighting it as their "top pick" in the leisure space for the 2024 financial year, particularly noting its promising performance in the lucrative US market.

Reporting by Josh White for Sharecast.com.

Market Movers

FTSE 100 (UKX) 7,728.50 0.22%

FTSE 250 (MCX) 19,216.90 0.13%

techMARK (TASX) 4,399.69 0.39%

FTSE 100 - Risers

Rolls-Royce Holdings (RR.) 334.20p 3.37%

AstraZeneca (AZN) 10,418.00p 3.21%

Vodafone Group (VOD) 67.10p 2.24%

SEGRO (SGRO) 866.20p 1.98%

InterContinental Hotels Group (IHG) 7,902.00p 1.83%

Barclays (BARC) 149.00p 1.55%

Smith & Nephew (SN.) 1,132.50p 1.39%

Melrose Industries (MRO) 618.60p 1.28%

Frasers Group (FRAS) 839.50p 1.21%

Intertek Group (ITRK) 4,479.00p 1.11%

FTSE 100 - Fallers

Centrica (CNA) 130.80p -5.97%

Beazley (BEZ) 570.00p -2.56%

Kingfisher (KGF) 222.60p -2.20%

NATWEST GROUP (NWG) 224.60p -2.14%

Fresnillo (FRES) 477.50p -2.05%

British American Tobacco (BATS) 2,369.50p -1.82%

Scottish Mortgage Inv Trust (SMT) 795.20p -1.61%

Prudential (PRU) 821.20p -1.58%

Rio Tinto (RIO) 5,428.00p -1.58%

Burberry Group (BRBY) 1,319.50p -1.42%

FTSE 250 - Risers

Currys (CURY) 64.20p 36.36%

Bank of Georgia Group (BGEO) 4,225.00p 6.56%

W.A.G Payment Solutions (WPS) 88.00p 5.77%

Renishaw (RSW) 4,240.00p 2.91%

Capital Gearing Trust (CGT) 4,655.00p 2.65%

Watches of Switzerland Group (WOSG) 434.60p 2.60%

Me Group International (MEGP) 135.20p 2.58%

Mobico Group (MCG) 84.80p 2.29%

Senior (SNR) 161.40p 2.28%

Auction Technology Group (ATG) 610.00p 2.18%

FTSE 250 - Fallers

Indivior (INDV) 1,347.00p -4.06%

Direct Line Insurance Group (DLG) 166.10p -2.87%

Baltic Classifieds Group (BCG) 231.00p -2.74%

FDM Group (Holdings) (FDM) 415.50p -2.35%

Aston Martin Lagonda Global Holdings (AML) 165.70p -2.30%

Abrdn (ABDN) 160.65p -2.22%

Elementis (ELM) 137.00p -2.14%

Moneysupermarket.com Group (MONY) 246.60p -1.83%

Hochschild Mining (HOC) 89.35p -1.71%

Monks Inv Trust (MNKS) 1,084.00p -1.63%

More News
16 Apr 2024 08:39

AstraZeneca's hails Imfinzi survival data on cancer form

(Alliance News) - AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced biliary tract cancer.

Read more
12 Apr 2024 12:55

EU regulator rules out link between weight-loss drugs and suicidal thoughts

April 12 (Reuters) - The European Union drug regulator found no evidence that a class of diabetes and weight-loss drugs such as Novo Nordisk's hugely popular Wegovy, are linked to suicidal thoughts, it said on Friday, ending a nine-month probe.

Read more
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.